Kwon et al. recorded the heart failure signs after an average of 3.5 months, anti-TNF therapy in 47 patients with rheumatoid arthritis, psoriatic arthritis, and CD; 82% of them represented new-onset cardiac failure (13). This evidence concerns the gene TNF and psoriatic arthritis.